Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: LIFE TECHNOLOGIES CORPORATION
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2023-08-31 to 2024-08-30
Current total value of award: $24975
Description: CELL LINE ENGINEERING SERVICES UTILIZING THE INVITROGEN? FLP-IN? 293 CELL LINE